Local News: Ashburn, VA 

 | 

Sign Up

 | 

Sign In

Forest Labs News Editors

News Widget

Display the Forest Labs news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Forest Labs News

News on Forest Labs (Ticker: FRX) continually updated from thousands of sources around the net.

1 hr ago | Reuters

Exclusive - Forest keen to bid for Irish drugmaker Elan - sources

The Federal Reserve on Wednesday said risks to the outlook for the U.S. economy and job market had eased since last fall, but it said it would keep buying $85 billion in bonds per month given the still-high level of unemployment.

Comment?

Related Topix: Financial Markets, Reuters, Biotech, Medicine, Healthcare Industry

Mon Jun 17, 2013

Investopedia

IRWD Launches Constella in Europe - Analyst Blog

Ironwood Pharmaceuticals, Inc. recently announced that it has launched Constella in collaboration with Almirall, S.A. in Europe.

Comment?

Related Topix: Irritable Bowel Syndrome, Medicine, Health, Biotech, Healthcare Industry

Investopedia

US Launch of Forest's Namenda XR - Analyst Blog

Forest Laboratories, Inc. recently announced the launch of its Alzheimer's drug, Namenda XR, in the US.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Dementia, Health

Fri Jun 14, 2013

AmericanBankingNews.com

Forest Laboratories Price Target Increased to $48.00 by Analysts at Cantor Fitzgerald

The firm currently has a "buy" rating on the stock. Cantor Fitzgerald's price objective would suggest a potential upside of 16.85% from the stock's previous close.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Forest Laboratories

Thu Jun 13, 2013

Boston.com

Ironwood drug for irritable bowel syndrome is now available in Europe

Ironwood Pharmaceuticals Inc. of Cambridge and its European partner, Almirall S.A. of Spain, said that a new Ironwood drug for irritable bowel syndrome with constipation is now available in Germany, the UK, and the Nordic countries.

Comment?

Related Topix: Irritable Bowel Syndrome, Medicine, Health, Biotech, Ironwood Pharmaceuticals, Healthcare Industry

Freshnews

Forest Announces U.S. Availability of New Once-Daily Namenda XR

Forest Laboratories, Inc. announced today that NAMENDA XR once-daily formulation is now available in pharmacies throughout the United States.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration, Alzheimer's, Health, Dementia

Wed Jun 12, 2013

AmericanBankingNews.com

Forest Laboratories Given New $48.00 Price Target at Jefferies Group

Jefferies Group's price target indicates a potential upside of 20.51% from the stock's previous close.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Forest Laboratories, Investment Banking, Financial Services, Jefferies Group, Investment Services

Tue Jun 11, 2013

Seeking Alpha

Forest Laboratories Inc. Presents at Goldman Sachs 34th Annual Global ...

Francis I. Perier - Chief Financial Officer, Executive Vice President of Finance & Administration and Member of Disclosure, Legal Compliance & Risk Management Committee All right, we're going to start, everybody.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

PE Hub

peHUB Second Opinion 6.11

Meanwhile, a Viola, New York man is outraged that his private information is being collected by someone other than advertisers.

Comment?

Related Topix: Viola, NY, Forest Laboratories, Biotech, Medicine, Healthcare Industry, Opinion

Reuters

UPDATE 1-Forest Labs to add Icahn aide to board, avert proxy fight

Forest Laboratories Inc said on Tuesday it will add a representative of Carl Icahn as an independent member to its board, averting a new proxy battle with the billionaire investor.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Mon Jun 10, 2013

PR-inside.com

Now Available: Acute Inflammation - Pipeline Review, H1 2013

This report provides information on the therapeutic development for Acute Inflammation, complete with latest updates, and special features on late-stage and discontinued projects.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Fri Jun 07, 2013

Reuters

Exclusive: Forest braces for third bout with Icahn

Forest Laboratories Inc is trying to avert yet another bitter proxy battle with billionaire investor Carl Icahn ahead of its annual investor meeting this summer, according to two sources familiar with the situation.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Marketing

Wed Jun 05, 2013

Theflyonthewall.com

On The Fly: Analyst Upgrade Summary

Check below for free stories on APA;BHI;CTXS;COP;CRM;RHP;TKR;DCO;ACC;LMOS;INFA;JOEZ;FRX;BBG;KED;QEP;BBBY the last two weeks.

Comment?

Related Topix: Manufacturing, Ducommun, Aerospace-Defense, Biotech, Medicine, Healthcare Industry

AmericanBankingNews.com

Argus Upgrades Forest Laboratories to Buy

The firm currently has a $46.00 target price on the stock. Argus' price objective would indicate a potential upside of 14.74% from the stock's previous close.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Forest Laboratories

Tue Jun 04, 2013

Seeking Alpha

The Dope On A Forest Labs Takeover

Carl Icahn lost a proxy battle in 2011 to leverage his 10% ownership stake into four seats on Forest Lab's board.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Eli Lilly, ImClone Systems, Pfizer, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals

Mon Jun 03, 2013

SBWire

Global Alzheimers Drugs Industry 2012-2016 Available Through MarketResearchReports.biz

TechNavio's analysts forecast the Global Alzheimer's Drugs market to grow at a CAGR of 3.26 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu May 30, 2013

HawaiiNews

Ironwood Pharma rises following analyst upgrade Shares of Ironwood...

Shares of Ironwood Pharmaceuticals Inc. rose Friday after a Wedbush analyst upgraded the stock, saying growth in prescriptions for the company's bowel drug Linzess has been better than he expected.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Irritable Bowel Syndrome, Health

Wed May 29, 2013

AmericanBankingNews.com

Forest Laboratories Upgraded to "Buy" at TheStreet

The analysts wrote, "Forest Laboratories has been upgraded by TheStreet Ratings from hold to buy.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Forest Laboratories

BioSpace

As Forest Laboratories, Inc. CEO Plans Retirement, the Feds Issue a New Subpoena

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Around the same time that Howard Solomon decided that he will soon retire as the long-standing ceo at Forest Laboratories, the drugmaker received a subpoena from the US Department of Justice concerning its Turdorza Pressair treatment for chronic obstructive ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Forest Laboratories, US News, Chronic Obstructive Pulmonary Disease, Health

Mon May 27, 2013

The Motley Fool

2 Biotech Stocks in Activist Investors' Crosshairs

Activist investors are no stranger to the health-care sector, an industry known for binary events and buyouts.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Ashburn Jobs